Reaction Details |
| Report a problem with these data |
Target | Death-associated protein kinase 3 |
---|
Ligand | BDBM50335638 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_714650 (CHEMBL1663328) |
---|
IC50 | 17±n/a nM |
---|
Citation | Pierre, F; Chua, PC; O'Brien, SE; Siddiqui-Jain, A; Bourbon, P; Haddach, M; Michaux, J; Nagasawa, J; Schwaebe, MK; Stefan, E; Vialettes, A; Whitten, JP; Chen, TK; Darjania, L; Stansfield, R; Anderes, K; Bliesath, J; Drygin, D; Ho, C; Omori, M; Proffitt, C; Streiner, N; Trent, K; Rice, WG; Ryckman, DM Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. J Med Chem54:635-54 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Death-associated protein kinase 3 |
---|
Name: | Death-associated protein kinase 3 |
Synonyms: | DAP kinase 3 | DAP-like kinase | DAPK3 | DAPK3_HUMAN | ZIP-kinase | ZIPK |
Type: | PROTEIN |
Mol. Mass.: | 52537.07 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_586564 |
Residue: | 454 |
Sequence: | MSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE
IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL
KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT
PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY
FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSGRKPERRRLKTT
RLKEYTIKSHSSLPPNNSYADFERFSKVLEEAAAAEEGLRELQRSRRLCHEDVEALAAIY
EEKEAWYREESDSLGQDLRRLRQELLKTEALKRQAQEEAKGALLGTSGLKRRFSRLENRY
EALAKQVASEMRFVQDLVRALEQEKLQGVECGLR
|
|
|
BDBM50335638 |
---|
n/a |
---|
Name | BDBM50335638 |
Synonyms: | 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | CHEMBL1230165 | US8168651, Compound TABLE 16.17 | US9062043, Table 13, Compound 17 | US9062043, Table 20b, Compound 12 |
Type | Small organic molecule |
Emp. Form. | C19H12ClN3O2 |
Mol. Mass. | 349.77 |
SMILES | OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21 |
Structure |
|